Rituxan and platelet count decreased 
Rituxan and platelet count decreased Patient Reports February 11, 2012
Rituxan Side Effects Report #4631399-9
Rituxan side effect was reported by a Health Professional from on Mar 24, 2005. Male patient, 64 years of age, weighting 140.0 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood pressure decreased, feeling hot, heart rate increased, hepatic failure, hyperhidrosis, infusion related reaction, platelet count decreased. Rituxan dosage: 680 MG, 1/WEEK, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5809107-5
Rituxan side effect was reported by a Health Professional from UNITED STATES on July 07, 2008. Female patient was diagnosed with thrombotic thrombocytopenic purpura and was treated with Rituxan. After drug was administered, patient experienced the following side effects: catheter related infection, encephalopathy, platelet count decreased. Rituxan dosage: unknown. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5445138-5
Rituxan side effect was reported by a Physician from UNITED STATES on May 29, 2007. Male patient, 14 years of age, weighting 330.7 lb, was diagnosed with systemic lupus erythematosus and was treated with Rituxan. After drug was administered, patient experienced the following side effects: platelet count decreased, pyrexia. Rituxan dosage: 375 MG/M2, X4, INTRAVENOUS; 375 MG/M2, X2, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5519351-2
Rituxan side effect was reported by a Physician from JAPAN on Nov 09, 2007. Female patient, weighting 149.9 lb, was diagnosed with systemic lupus erythematosus and was treated with Rituxan. After drug was administered, patient experienced the following side effects: diarrhoea, platelet count decreased, pyrexia, urticaria, vomiting. Rituxan dosage: 500 MG, QD. During the same period patient was treated with ULCERLMIN, PRECIPITATED CALCIUM CARBONATE, ROCALTROL, ACTONEL, OMEPRAL, CYTOTEC, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5592203-8
Rituxan side effect was reported by a Physician from JAPAN on Jan 14, 2008. Female patient, weighting 149.9 lb, was diagnosed with systemic lupus erythematosus and was treated with Rituxan. After drug was administered, patient experienced the following side effects: diarrhoea, platelet count decreased, pyrexia, urticaria, vomiting. Rituxan dosage: 500 MG, QD. During the same period patient was treated with ULCERLMIN, PRECIPITATED CALCIUM CARBONATE, ROCALTROL, ACTONEL, OMEPRAL, CYTOTEC, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5603004-6
Rituxan side effect was reported by a Physician from JAPAN on Jan 17, 2008. Female patient, weighting 149.9 lb, was diagnosed with systemic lupus erythematosus and was treated with Rituxan. After drug was administered, patient experienced the following side effects: diarrhoea, fibrin d dimer increased, platelet count decreased, pyrexia, urticaria, vomiting. Rituxan dosage: 500 MG, QD. During the same period patient was treated with ULCERLMIN, PRECIPITATED CALCIUM CARBONATE, ROCALTROL, ACTONEL, OMEPRAL, CYTOTEC, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5113554-7
Rituxan side effect was reported by a Physician from JAPAN on Sept 08, 2006. Female patient, 74 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Rituxan. After drug was administered, patient experienced the following side effects: adenovirus infection, disseminated intravascular coagulation, neutropenia, platelet count decreased. Rituxan dosage: 100 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient died on 07/01/2006.
Rituxan Side Effects Report #4745707-1
Rituxan side effect was reported by a Physician from JAPAN on July 29, 2005. Male patient, 88 years of age, weighting 123.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood creatinine increased, blood potassium increased, platelet count decreased, pneumonia
, proteinuria, sepsis . Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNONINE, HYDROCORTISONE, FAMOTIDINE. Patient died on 04/08/2005.Rituxan Side Effects Report #4764408-7
Rituxan side effect was reported by a Physician from JAPAN on Aug 24, 2005. Male patient, 88 years of age, weighting 123.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood creatinine increased, blood potassium increased, blood urea increased, haemoglobin decreased, platelet count decreased, pneumonia
, protein urine present. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDONINE, HYDROCORTISONE, FAMOTIDINE. Patient died on 04/08/2005.Rituxan Side Effects Report #4900862-5
Rituxan side effect was reported by a Physician from JAPAN on Jan 24, 2006. Male patient, 83 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, haematocrit decreased, interstitial lung disease, platelet count decreased, pleural effusion. Rituxan dosage: 375 MG/M2, UNK, INTRAVENOUS. Patient recovered.
Rituxan Side Effects Report #4803862-9
Rituxan side effect was reported by a Physician from JAPAN on Oct 03, 2005. Male patient, 79 years of age, weighting 101.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: convulsion, febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 532 MG, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, POLARAMINE, LOXONIN. Patient died on 11/07/2004.
Rituxan Side Effects Report #4772894-1
Rituxan side effect was reported by a Physician from JAPAN on Sept 06, 2005. Female patient, 77 years of age, weighting 88.63 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, neutrophil percentage decreased, neutrophil percentage increased, platelet count decreased, pruritus, white blood cell count decreased. Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, ONCOVIN, PREDISOLONE, ACETAMINOPHEN, ZADITEN, TOPOTECAN. Patient recovered.
Rituxan Side Effects Report #4875004-5
Rituxan side effect was reported by a Physician from JAPAN on Dec 20, 2005. Female patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood pressure decreased, blood sodium decreased, chills, difficulty in walking, dizziness
, haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 550 MG, UNK; INTRAVENOUS. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, ONCOVIN, PREDONINE, IBUPROFEN, DEXCHLORPHENIRAMINE MALEATE, NIFEDIPINE. Patient recovered.Rituxan Side Effects Report #4684542-X
Rituxan side effect was reported by a Health Professional from on May 20, 2005. Female patient, 73 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haematocrit decreased, neutropenia, platelet count decreased, white blood cell count decreased. Rituxan dosage: 573 MG, INTRAVENOUS. During the same period patient was treated with OXYCONTIN. Patient recovered.
Rituxan Side Effects Report #4783674-5
Rituxan side effect was reported by a Consumer or non-health professional from CHINA on Sept 21, 2005. Male patient, 70 years of age, weighting 88.18 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 477.261MG, Q3W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, POLARAMINE, HYDROCORTONE, LEVOFLOXACIN, FLUCONAZOLE. Patient recovered.
Rituxan Side Effects Report #4810041-8
Rituxan side effect was reported by a Physician from JAPAN on Oct 11, 2005. Male patient, 70 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, haemoglobin decreased, lymphocyte percentage increased, neutrophil percentage decreased, platelet count decreased, red blood cell count decreased. Rituxan dosage: 530 MG, QD. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, GRANISETRON, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PANIPENEM. Patient recovered.
Rituxan Side Effects Report #4810392-7
Rituxan side effect was reported by a Physician from JAPAN on Oct 11, 2005. Male patient, 70 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood creatine increased, blood lactate dehydrogenase increased, blood urea increased, haemoglobin decreased, lymphocyte percentage decreased, lymphocyte percentage increased, neutrophil percentage decreased, platelet count decreased, red blood cell count decreased. Rituxan dosage: 530 MG, QD,. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, GRANISETRON, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PANIPENEM. Patient recovered.
Rituxan Side Effects Report #4811725-8
Rituxan side effect was reported by a Physician from JAPAN on Oct 11, 2005. Male patient, 70 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal pain
, blood lactate dehydrogenase increased, cough, haemoglobin decreased, hypokalaemia, neutrophil percentage decreased, platelet count decreased, pleurisy, pyrexia. Rituxan dosage: 530 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE SULPHATE, PREDNISOLONE ACETATE, DEXAMETHASONE PHOSPHATE, GRANISETRON, AMIKACIN SULPHATE, AMPHOTERICIN B. Patient recovered.Rituxan Side Effects Report #4649422-4
Rituxan side effect was reported by a Physician from on Apr 28, 2005. Male patient, 69 years of age, weighting 178.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: condition aggravated, haematemesis, neuropathy peripheral, platelet count decreased, respiratory distress, white blood cell count decreased. Rituxan dosage: 490 MG IV. During the same period patient was treated with ZEVALIN, PREDNISONE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4688523-1
Rituxan side effect was reported by a Physician from on May 26, 2005. Female patient, 69 years of age, weighting 94.80 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: neutropenia, platelet count decreased, white blood cell count decreased. Rituxan dosage: 470 MG, INTRAVENOUS. During the same period patient was treated with NOVANTRONE, PARAPLATIN, ETOPOSIDE, PREDNISOLONE ACETATE, ZONISAMIDE, MECOBALAMIN, ADENOSINE TRIPHOSPHATE DI, BICARBONATE IN PLASTIC CONTAINER. Patient recovered.
Rituxan Side Effects Report #4716481-X
Rituxan side effect was reported by a Physician from JAPAN on June 28, 2005. Male patient, 68 years of age, weighting 112.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, blood pressure decreased, neutropenia, platelet count decreased, sepsis
, white blood cell count decreased. Rituxan dosage: 570 MG, INTRAVENOUS. During the same period patient was treated with ENDOXAN, ADRIAMYCIN PFS, ONCOVIN, ETOPOSIDE, PREDONINE, LOXONIN, POLARAMINE. Patient recovered.Rituxan Side Effects Report #4873335-6
Rituxan side effect was reported by a Physician from JAPAN on Dec 19, 2005. Male patient, 68 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: body temperature decreased, hepatic function abnormal, neutrophil percentage decreased, neutrophil percentage increased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 600 MG, SINGLE, INTRAVENOUS. During the same period patient was treated with PARAPLATIN, CYTARABINE, DECADRON, DIPHENHYDRAMINE, ACETAMINOPHEN, LOXOPROFEN. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5092154-1
Rituxan side effect was reported by a Physician from UNITED STATES on Aug 16, 2006. Female patient, 66 years of age, weighting 117.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: bone marrow failure, disease progression, haematemesis, lymphoma
, neutropenia, platelet count decreased, pyrexia. Rituxan dosage: 375 MG/M2, Q2W, INTRAVENOUS. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, NEULASTA. Patient died on 08/03/2006.Rituxan Side Effects Report #4718908-6
Rituxan side effect was reported by a Physician from JAPAN on July 08, 2005. Female patient, 66 years of age, weighting 141.1 lb, was diagnosed with non-hodgkin's lymphoma, diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, haemoglobin decreased, nausea
, neutrophil count decreased, platelet count decreased. Rituxan dosage: 590 MG, INTRAVENOUS. During the same period patient was treated with IFOSFAMIDE, PARAPLATIN, VEPESID, MESNA, POLARAMINE, IBUPROFEN. Patient recovered.Rituxan Side Effects Report #4707423-1
Rituxan side effect was reported by a Physician from JAPAN on June 20, 2005. Male patient, 65 years of age, weighting 91.49 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: neutrophil percentage decreased, neutrophil percentage increased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 500 MG, IV DRIP. During the same period patient was treated with PARAPLATIN, NOVANTRONE, PREDONINE, VEPESID, LOXONIN, POLARAMINE. Patient recovered.
Rituxan Side Effects Report #4902361-3
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Jan 20, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gangrene, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, ENDOXAN, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4911383-8
Rituxan side effect was reported by a Physician from JAPAN on Feb 06, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gangrene, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, ENDOXAN, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4930277-5
Rituxan side effect was reported by a Physician from JAPAN on Feb 15, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, diabetic gangrene, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, ENDOXAN, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4933998-3
Rituxan side effect was reported by a Physician from JAPAN on Mar 01, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gangrene, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Rituxan dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with THERARUBICIN, ENDOXAN, ONCOVIN, METHOTREXATE, FAMOTIDINE, TEGRETOL, VERAPAMIL, ISONIAZID. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4741535-1
Rituxan side effect was reported by a Physician from JAPAN on July 25, 2005. Male patient, 63 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: dementia
, depression , malaise, neoplasm, pancreatic disorder, platelet count decreased, pyrexia, restlessness, urinary incontinence . Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FARMORUBICIN, ONCOVIN, PREDONINE, SEROTONE, PRIMERAN, ALBUMIN, HYDROCORTONE. Patient recovered.Rituxan Side Effects Report #4877242-4
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Male patient, 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 570 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, FAMOTIDINE, CETRAXATE HYDROCHLORIDE, MAGNESIUM OXIDE, RILMAZAFONE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4661228-9
Rituxan side effect was reported by a Physician from on Apr 26, 2005. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: chills, diarrhoea, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 520 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE. Patient recovered.
Rituxan Side Effects Report #4694959-5
Rituxan side effect was reported by a Physician from on June 08, 2005. Female patient, 60 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Rituxan dosage: 520 MG, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN HYDROCHLORIDE, PREDNISONE, IBUPROFEN, CHLORPHENIRAMINE MALEATE. Patient recovered.
Rituxan Side Effects Report #4717934-0
Rituxan side effect was reported by a Physician from JAPAN on July 05, 2005. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: chills, diarrhoea, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 520 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE. Patient recovered.
Rituxan Side Effects Report #4686707-X
Rituxan side effect was reported by a Physician from on May 25, 2005. Female patient, 59 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, liver disorder, platelet count decreased. Rituxan dosage: 500 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with RESTAMIN, IBUPROFEN, MUCOSTA, FAMOTIDINE, MAGNESIUM OXIDE. Patient recovered.
Rituxan Side Effects Report #4710573-7
Rituxan side effect was reported by a Physician from JAPAN on June 23, 2005. Female patient, 59 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, liver disorder, platelet count decreased. Rituxan dosage: 500 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with RESTAMIN, IBUPROFEN, MUCOSTA, FAMOTIDINE, MAGNESIUM OXIDE. Patient recovered.
Rituxan Side Effects Report #4868763-9
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Dec 13, 2005. Female patient, 57 years of age, weighting 123.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: b-cell lymphoma, febrile neutropenia, gingival pain, haemoglobin decreased, neoplasm recurrence, platelet count decreased, white blood cell count decreased. Rituxan dosage: 250 MG INTRAVENOUS. During the same period patient was treated with ZEVALIN, SHL. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4954446-3
Rituxan side effect was reported by a Health Professional from JAPAN on Mar 13, 2006. Female patient, 57 years of age, weighting 123.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: febrile neutropenia, gingival pain, haematocrit decreased, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: unknown. During the same period patient was treated with ZEVALIN, SHL. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4729597-9
Rituxan side effect was reported by a Physician from JAPAN on July 15, 2005. Male patient, 56 years of age, weighting 116.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: adenoviral haemorrhagic cystitis, haematocrit decreased, haemoglobin decreased, platelet count decreased, stem cell transplant, white blood cell count decreased. Rituxan dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ONCOVIN, ADRIAMYCIN PFS, PREDONINE, LEUSTATIN, NOVANTRON. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4788909-0
Rituxan side effect was reported by a Physician from JAPAN on Sept 22, 2005. Male patient, 56 years of age, weighting 116.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: adenoviral haemorrhagic cystitis, haematocrit decreased, haemoglobin decreased, hypogammaglobulinaemia, platelet count decreased, stem cell transplant, white blood cell count decreased. Rituxan dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ONCOVIN, ADRIAMYCIN PFS, PREDONINE, LEUSTATIN, NOVANTRONE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4694952-2
Rituxan side effect was reported by a Physician from on June 06, 2005. Male patient, 55 years of age, weighting 145.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, lymphocyte percentage decreased, neutrophil count decreased, neutrophil percentage increased, platelet count decreased. Rituxan dosage: 630 MG IV DRIP. During the same period patient was treated with CYCLOPHOSPHAMIDE, VEPESID, CYTARABINE, DECADRON, LOXONIN, DEXCHLORPHENIRAMINE MALEATE. Patient recovered.
Rituxan Side Effects Report #4766978-1
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Sept 02, 2005. Female patient, 55 years of age, weighting 141.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: basophil percentage increased, blood immunoglobulin g decreased, blood immunoglobulin m decreased, blood sodium decreased, cytomegalovirus infection
, eosinophil percentage increased, neutrophil percentage decreased, platelet count decreased, pyrexia. Rituxan dosage: 550 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, CYTARABINE, DECADRON, IFOSFAMIDE, PARAPLATIN, CELESTAMINE, PYRINAZIN. Patient recovered.Rituxan Side Effects Report #4796328-6
Rituxan side effect was reported by a Physician from JAPAN on Sept 28, 2005. Male patient, 54 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium decreased, c-reactive protein increased, hypercalcaemia, neutrophil count decreased, neutrophil percentage increased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 600 MG, 600 MG, INTRAVENOUS; 600 MG; 600 MG. During the same period patient was treated with CYTARABINE, CISPLATIN, IBUPROFEN, DIPHENHYDRAMINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4940900-7
Rituxan side effect was reported by a Physician from JAPAN on Mar 06, 2006. Male patient, 54 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium decreased, hypercalcaemia, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 600 MG INTRAVENOUS. During the same period patient was treated with CYTARABINE, CISPLATIN, IBUPROFEN, DIPHENHYDRAMINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4690711-5
Rituxan side effect was reported by a Physician from on May 31, 2005. Male patient, 53 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood urea increased, hyperbilirubinaemia, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Rituxan Side Effects Report #4694957-1
Rituxan side effect was reported by a Physician from on June 06, 2005. Female patient, 51 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: lymphocyte percentage decreased, lymphocyte percentage increased, neutrophil count decreased, neutrophil percentage increased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 530 MG IV DRIP. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ONCOVIN, PREDONINE, LOXONIN, DEXCHLORPHENIRAMINE MALEATE. Patient recovered.
Rituxan Side Effects Report #4779010-0
Rituxan side effect was reported by a Physician from JAPAN on Sept 15, 2005. Male patient, 51 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, anaphylactoid reaction, hepatic function abnormal, lymphadenopathy, neutrophil count decreased, pharyngitis, platelet count decreased, white blood cell count decreased. Rituxan dosage: 600 MG INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYTARABINE, DECADRON, ETOPOSIDE, POLARAMINE, LOXONIN. Patient recovered.
Rituxan Side Effects Report #4705685-8
Rituxan side effect was reported by a Physician from on June 10, 2005. Female patient, 50 years of age, weighting 85.98 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: bone marrow disorder, haemoglobin decreased, leukopenia, neutropenia, platelet count decreased. Rituxan dosage: 500 MG, IV DRIP. During the same period patient was treated with POLARAMINE, IBUPROFEN. Patient recovered.
Rituxan Side Effects Report #4709352-6
Rituxan side effect was reported by a Physician from JAPAN on June 22, 2005. Female patient, 49 years of age, weighting 136.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, hepatic function abnormal, pharynx discomfort, platelet count decreased, pruritus, urticaria, white blood cell count decreased. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, CYCLOCIDE, DECADRON, POLARAMINE, LOXONIN. Patient recovered.
Rituxan Side Effects Report #4733566-2
Rituxan side effect was reported by a Physician from JAPAN on July 18, 2005. Female patient, 49 years of age, weighting 136.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, hepatic function abnormal, pharynx discomfort, platelet count decreased, pruritus, urticaria, white blood cell count decreased. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, CYTARABINE, DECADRON, POLARAMINDE, LOXONIN. Patient recovered.
Rituxan Side Effects Report #4700676-5
Rituxan side effect was reported by a Physician from on June 10, 2005. Female patient, 47 years of age, weighting 108.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: leukopenia, neutrophil percentage decreased, neutrophil percentage increased, platelet count decreased. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with BLEOMYCIN, IFOSFAMIDE, DECADRON, ATARAX, HERCEPTIN. Patient recovered.
Rituxan Side Effects Report #4709972-9
Rituxan side effect was reported by a Physician from JAPAN on June 21, 2005. Female patient, 47 years of age, weighting 108.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: leukopenia, neutrophil percentage decreased, platelet count decreased. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with VINESINE, BLEOMYCIN, IFOSFAMIDE, DECADRON, ATARAX, HERCEPTIN. Patient recovered.
Rituxan Side Effects Report #4716495-X
Rituxan side effect was reported by a Physician from JAPAN on July 01, 2005. Male patient, 45 years of age, weighting 143.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, blood fibrinogen decreased, brain stem infarction, complications of transplant surgery, depressed level of consciousness, encephalitis viral, platelet count decreased, white blood cell count decreased. Rituxan dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VEPESID, CYTARABINE, FLUDARABINE PHOSPHATE, ALKERAN, DECADRON, LOXONIN, POLARAMINE. Patient died on 02/13/2002.
Rituxan Side Effects Report #4724262-6
Rituxan side effect was reported by a Physician from JAPAN on July 20, 2005. Male patient, 45 years of age, weighting 143.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, blood fibrinogen decreased, brain stem infarction, depressed level of consciousness, encephalitis viral, graft complication, platelet count decreased, white blood cell count decreased. Rituxan dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VEPESID, CYTARABINE, FLUDARABINE PHOSPHATE, ALKERAN, DECADRON, LOXONIN, POLARAMINE. Patient died on 02/13/2002.
Rituxan Side Effects Report #4690189-1
Rituxan side effect was reported by a Physician from on June 01, 2005. Male patient, 42 years of age, weighting 116.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: jaundice
, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 580 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DECADRON, LOXONIN, POLARAMIN, ETOPOSIDE, CYCLOCID. Patient was hospitalized. Patient recovered.Rituxan Side Effects Report #4716825-9
Rituxan side effect was reported by a Physician from JAPAN on June 29, 2005. Male patient, 42 years of age, weighting 116.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: jaundice
, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 580 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, CYTARABINE, DECADRON, LOXONIN, DEXCHLORPHENIRAMINE MALEATE. Patient was hospitalized. Patient recovered.Rituxan Side Effects Report #4704616-4
Rituxan side effect was reported by a Physician from on June 16, 2005. Male patient, 37 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal neoplasm, anaemia, blood lactate dehydrogenase increased, condition aggravated, headache
, neutrophil percentage decreased, platelet count decreased, protein total decreased, white blood cell count decreased. Rituxan dosage: 700 MG, IV DRIP. During the same period patient was treated with CYCLOPHOSPHAMIDE, DEXAMETHASONE, ETOPOSIDE, CYTARABINE, FILGRASTIM, DOXORUBICIN, VINCRISTINE. Patient recovered.Rituxan Side Effects Report #4976254-X
Rituxan side effect was reported by a Physician from JAPAN on Apr 03, 2006. Female patient, 30 years of age, weighting 99.21 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: platelet count decreased, white blood cell count decreased. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE, ENDOXAN, ONCOVIN, PREDONINE, METHOTREXATE. Patient recovered.
Rituxan Side Effects Report #5645582-7
Rituxan side effect was reported by a Physician from JAPAN on Feb 22, 2008. Female patient, weighting 117.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood pressure decreased, disseminated intravascular coagulation, headache
, platelet count decreased, pyrexia. Rituxan dosage: 375 MG/M2, QD. Patient recovered.Rituxan Side Effects Report #4738999-6
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2005. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: platelet count decreased, white blood cell count decreased. Rituxan dosage: unknown. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4577783-3
Rituxan side effect was reported by a Physician from on Jan 28, 2005. Male patient, 62 years of age, was diagnosed with mantle cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: back pain
, culture urine positive, enterococcal infection, fatigue, febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased. Rituxan dosage: 375 MG/M2, Q3W; INTRAVENOUS. During the same period patient was treated with GENASENSE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ACETAMINOPHEN, ALLOPURINOL, VERAPAMIL. Patient was hospitalized. Patient recovered.Rituxan Side Effects Report #4678285-6
Rituxan side effect was reported by a Physician from on May 13, 2005. Female patient, 53 years of age, was diagnosed with mantle cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time shortened, antithrombin iii decreased, blood glucose increased, deep vein thrombosis
, fibrin degradation products increased, haemoglobin decreased, platelet count decreased, subileus. Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, EPIRUBICIN, PREDNISONE, CILOSTAZOL, BETAMETHASONE PHOSPHATE. Patient recovered.Rituxan Side Effects Report #4713393-2
Rituxan side effect was reported by a Physician from JAPAN on June 28, 2005. Female patient, 53 years of age, was diagnosed with mantle cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood glucose increased, deep vein thrombosis
, haemoglobin decreased, platelet count decreased, subileus, white blood cell count decreased. Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, EPIRUBICIN HYDROCHLORIDE, PREDNISONE, CILOSTAZOL, BETAMETHASONE PHOSPHATE. Patient recovered.Rituxan Side Effects Report #5066583-6
Rituxan side effect was reported by a Physician from UNITED STATES on July 18, 2006. Male patient, 65 years of age, was diagnosed with lymphoma
and was treated with Rituxan. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome, neutropenia, platelet count decreased, subcutaneous abscess, white blood cell count decreased. Rituxan dosage: unknown. During the same period patient was treated with FLUDARABINE, TIAZAC, CELEXA, CLONIDINE. Patient was hospitalized. Patient recovered.Rituxan Side Effects Report #5081336-0
Rituxan side effect was reported by a Physician from UNITED STATES on Aug 02, 2006. Male patient, 64 years of age, was diagnosed with lymphoma
and was treated with Rituxan. After drug was administered, patient experienced the following side effects: bone marrow toxicity, haemoglobin decreased, neutropenia, platelet count decreased. Rituxan dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.Rituxan Side Effects Report #4830703-6
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Nov 01, 2005. Male patient, 64 years of age, weighting 130.1 lb, was diagnosed with lymphoma
and was treated with Rituxan. After drug was administered, patient experienced the following side effects: neutropenia, platelet count decreased, white blood cell count decreased. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with PARAPLATIN, CYTARABINE, TOPOTECAN, DECADRON, VEPESID, ONCOVIN, THERARUBICIN, PREDISOLONE. Patient recovered.Rituxan Side Effects Report #4875029-X
Rituxan side effect was reported by a Physician from JAPAN on Dec 20, 2005. Male patient, 64 years of age, was diagnosed with lymphoma
and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, anorexia, blood potassium increased, fatigue, hypoaesthesia, platelet count decreased, white blood cell count decreased. Rituxan dosage: unknown. During the same period patient was treated with IFOSFAMIDE, PARAPLATIN, VEPESID, BRUFEN. Patient recovered.Rituxan Side Effects Report #4818721-5
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 21, 2005. Male patient, 63 years of age, was diagnosed with lymphoma
and was treated with Rituxan. After drug was administered, patient experienced the following side effects: buttock pain, ewing's sarcoma, fatigue, myalgia, paraesthesia, platelet count decreased, red blood cell count abnormal, white blood cell count abnormal. Rituxan dosage: unknown. Patient recovered.Rituxan Side Effects Report #4978854-X
Rituxan side effect was reported by a Physician from JAPAN on Apr 07, 2006. Male patient, 63 years of age, was diagnosed with lymphoma
, diffuse large b-cell lymphoma, hypoalbuminaemia, sepsis and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood pressure decreased, coma hepatic, hepatitis b , hepatitis fulminant, platelet count decreased, pneumonia . Rituxan dosage: 570 MG, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, BLEOMYCIN, DOXORUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, VINCRISTINE, DEXAMETHASONE PHOSPHATE, SERUM ALBUMIN, POLYETHYLENE GLYCOL. Patient died on 03/16/2004.Rituxan Side Effects Report #4778801-X
Rituxan side effect was reported by a Consumer or non-health professional from JAPAN on Sept 15, 2005. Female patient, 32 years of age, was diagnosed with lymphoma
and was treated with Rituxan. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 530 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN HYDROCHLORIDE, PREDNISONE, BURFEN, POLARAMINE, GASLON N, MARZULENE. Patient recovered.Rituxan Side Effects Report #5269951-2
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 01, 2007. Female patient, 78 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abnormal faeces, chest discomfort, fatigue, international normalised ratio increased, platelet count decreased. Rituxan dosage: unknown. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5099051-6
Rituxan side effect was reported by a Physician from UNITED STATES on Feb 28, 2006. Male patient, 78 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Rituxan. After drug was administered, patient experienced the following side effects: platelet count decreased. Rituxan dosage: 375 MG/M2, 1/WEEK. Patient recovered.
Rituxan Side Effects Report #5391607-6
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2007. Female patient, 63 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Rituxan. After drug was administered, patient experienced the following side effects: platelet count decreased. Rituxan dosage: unknown. Patient recovered.
Rituxan Side Effects Report #4740551-3
Rituxan side effect was reported by a Physician from UNITED STATES on Sept 27, 2004. Female patient, 42 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Rituxan. After drug was administered, patient experienced the following side effects: platelet count decreased. Rituxan dosage: 375 MG/M2, Q2W, INTRAVENOUS. During the same period patient was treated with PREDNISONE. Patient recovered.
Rituxan Side Effects Report #4743960-1
Rituxan side effect was reported by a Physician from UNITED STATES on Sept 27, 2004. Female patient, 42 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Rituxan. After drug was administered, patient experienced the following side effects: platelet count decreased. Rituxan dosage: 375 MG/M2, Q2W, INTRAVENOUS. During the same period patient was treated with PREDNISONE. Patient recovered.
Rituxan Side Effects Report #5268558-0
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2007. Female patient, 28 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abortion induced, platelet count decreased, pregnancy
. Rituxan dosage: 600 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with IMMUNE GLOBULIN, PREDNISOLOLNE. Patient recovered.Rituxan Side Effects Report #5147269-6
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Female patient, 28 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abortion induced, condition aggravated, platelet count decreased, pregnancy
. Rituxan dosage: 600 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with IMMUNE GLOBULIN, PREDNISOLONE. Patient recovered.Rituxan Side Effects Report #5646738-X
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 25, 2008. Female patient was diagnosed with idiopathic thrombocytopenic purpura and was treated with Rituxan. After drug was administered, patient experienced the following side effects: platelet count decreased. Rituxan dosage: 795 MG, 1/WEEK. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #6097942-0
Rituxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 19, 2009. Male patient, 71 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: colitis, disease progression, platelet count decreased. Rituxan dosage: unknown. During the same period patient was treated with REVLIMID, COREG, WELLBUTRIN, VALTREX, LIPITOR, FLOMAX, OMEPRAZOLE, OXYCONTIN. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5831471-1
Rituxan side effect was reported by a Physician from UNITED STATES on July 25, 2008. Male patient, weighting 183.0 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood potassium decreased, blood urea increased, cardio-respiratory arrest, cholelithiasis, neutropenia, platelet count decreased, pneumonia
, sepsis . Rituxan dosage: 375 MG/M2, Q3W. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ENZASTAURIN, LISINOPRIL, METOPROLOL. Patient died on 03/31/2008.Rituxan Side Effects Report #4739050-4
Rituxan side effect was reported by a Pharmacist from UNITED STATES on Sept 16, 2004. Female patient, 75 years of age, weighting 136.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malaise, platelet count decreased, pyrexia, rash
. Rituxan dosage: 610 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, IBUPROFEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Rituxan Side Effects Report #4741984-1
Rituxan side effect was reported by a Pharmacist from UNITED STATES on Sept 16, 2004. Female patient, 75 years of age, weighting 136.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituxan. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malaise, platelet count decreased, pyrexia, rash
. Rituxan dosage: 610 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, IBUPROFEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Rituxan Side Effects Report #4548661-0
Rituxan side effect was reported by a Health Professional from on Jan 07, 2005. Male patient, 73 years of age, weighting 184.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Rituxan. After drug was administered, patient experienced the following side effects: febrile neutropenia, platelet count decreased. Rituxan dosage: 375 MG /M2 IV Q 21 DAY =731 MG. During the same period patient was treated with PENTOSTATION. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4825224-0
Rituxan side effect was reported by a Health Professional from JAPAN on Oct 27, 2005. Female patient, 43 years of age, weighting 105.8 lb, was diagnosed with b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, haemoglobin decreased, neutropenia, peritoneal perforation, peritonitis, platelet count decreased, white blood cell count decreased. Rituxan dosage: 545.62 MG, SINGLE, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISONE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE. Patient recovered.
Rituxan Side Effects Report #5713049-3
Rituxan side effect was reported by a Health Professional from UNITED STATES on Apr 01, 2008. Female patient was diagnosed with b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood sodium decreased, febrile neutropenia, haematocrit decreased, neutropenic sepsis, platelet count decreased. Rituxan dosage: 375 MG/M2, Q3W. During the same period patient was treated with ENZASTAURIN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, CANDESARTAN CILEXETIL, DEXTROPROPOXYPHEN NAPSYLATE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #4775474-7
Rituxan side effect was reported by a Physician from UNITED STATES on Sept 21, 2005. Female patient, 70 years of age, was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, haemoglobin decreased, platelet count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, DOXIL. Patient recovered.Rituxan Side Effects Report #5072728-4
Rituxan side effect was reported by a Physician from UNITED STATES on July 21, 2006. Male patient, 64 years of age, was treated with Rituxan. After drug was administered, patient experienced the following side effects: bone marrow toxicity, haemoglobin decreased, neutropenia, platelet count decreased. Rituxan dosage: unknown. Patient recovered.